Avanos Medical Executives to Address Investors at Citizens Life Sciences Conference
Event summary
- Avanos Medical CEO Dave Pacitti and CFO Scott Galovan will participate in a fireside chat at the 2026 Citizens Life Sciences Conference.
- The conference will be held on Wednesday, March 11, 2026, at approximately 1:05 p.m. Eastern Time.
- A webcast of the presentation will be available on the Avanos Medical investor relations website and archived afterward.
- The event provides a platform for Avanos Medical to communicate directly with investors and analysts.
The big picture
Avanos Medical's participation in the Citizens Life Sciences Conference signals a continued effort to engage with the investment community and communicate its strategic direction. The fireside chat format suggests a desire for a more interactive and transparent dialogue with investors, potentially addressing concerns or highlighting opportunities within the medical device sector. This event comes as the broader healthcare industry faces increased scrutiny regarding pricing and innovation, requiring companies like Avanos to clearly articulate their value proposition.
What we're watching
- Growth Strategy
- The conference presentation will likely reveal details about Avanos Medical's plans to maintain its market positions and expand into new categories, which investors should scrutinize for realistic growth projections.
- Financial Outlook
- Scott Galovan’s commentary on the company’s financial performance and outlook will be key to assessing Avanos Medical’s ability to navigate potential economic headwinds and maintain profitability.
- Opioid Reduction
- Given the company's stated commitment to reducing opioid use, the presentation should clarify how Avanos Medical is measuring and achieving progress in this area, and whether this is translating into tangible financial benefits.
Related topics